Objective: Randomized controlled trials (RCTs) in obesity are plagued by missing data due to participant dropouts. Most methodologists and regulatory bodies agree that the primary analysis of such RCTs should be based on the intent-to-treat (ITT) principle, such that all randomized subjects are included in the analysis, even those who dropped out. Unfortunately, some authors do not include an ITT analysis in their published reports. Here we show that one form of ITT analysis, baseline observation carried forward (BOCF), can be performed utilizing only information available in a published complete-case (CC) analysis, permitting readers, editors, meta-analysts and regulators to easily conduct their own ITT analyses when the original authors do not report one. Method: We mathematically derive a simple method for estimating and testing treatment effects using the BOCF to allow a more conservative comparison of treatment effects when there are dropouts in a clinical trial. We provide two examples of this method using available CC analysis data from reported obesity trials to illustrate the application for readers who wish to determine a range of treatment effects based on published summary statistics. Conclusion: Commonly used CC analyses may lead to inflated type I error rates and/or treatment effect estimates. The method described herein can be useful for researchers who wish to estimate a conservative range of plausible treatment effects based on limited reported data. Limitations of this method are discussed.
Introduction
Randomized controlled trials (RCTs) are the gold standard for providing unbiased estimates and tests of the causal effects of obesity treatment and prevention strategies. Despite increased efforts to minimize the loss of participation before the study protocol is completed, dropouts remain a near-ubiquitous phenomenon. 1 There are many statistical methods available to accommodate missing data and to use all available data to estimate and test treatment effects. 2, 3 Although the intention-to-treat (ITT) principle is commonly accepted as an appropriate foundation for primary analyses, many researchers continue to use only a complete-case (CC) analysis, which may introduce significant bias in tests and estimates of treatment effects when there are dropouts. 2, 3 In a 2010 analysis of obesity trials, CC analysis was the most common method used (34% of papers). 4 The prevalence of CC analysis creates a problem for anyone (for example, readers, clinicians, consumers, regulatory agencies, metaanalysts) who wishes to rely on these papers to draw confident conclusions about the efficacy of the treatment studied.
There are several approaches to ITT analysis: most authors define it as an analysis including all cases who were randomized to a treatment arm, although a modified approach is to include only those cases who were randomized and received at least one exposure to the assigned treatment. 5 One method of ITT analysis, which has been recommended by some authors is baseline observation carried forward (BOCF). [6] [7] [8] BOCF is similar to the LOCF (last observation carried forward) in that the imputation is applied to participants who drop out of the study before the first post-baseline measure is taken. In LOCF, participants have the last value recorded carried forward depending on whether exposure to treatment is received. In BOCF, for any subject who does not have any post-baseline outcome (for example, weight) measurement at the endpoint under study, one simply imputes the baseline value for that variable. This means that if change in the variable (for example, weight loss or percent weight loss) is analyzed as the outcome, for all subjects who do not have a value at the study endpoint, one simply inserts the value as zero, for 'no change'. Then the complete data file can be analyzed with conventional methods.
We are not advocating BOCF as a method in general. Single imputation methods, of which BOCF is one, have serious disadvantages 6, 9 and BOCF in particular is strictly valid only under the assumption that all subjects who dropped out returned exactly to their baseline value on the outcome measure. BOCF is thus likely to be biased and highly conservative in practice. Nevertheless, when no other ITT analysis is available, BOCF can be used to place a plausible (though not definitive) lower bound point estimate on treatment effects. 6 In light of the frequently absent information from ITT analyses in published obesity RCTs, we provide a method for any reader, researcher or regulatory agent to calculate a more conservative estimate of treatment effects for a published study using commonly available data supplied within most papers. We provide the mathematical derivation and show two examples from published studies that illustrate the application.
Materials and methods

Notation
X T : The mean weight loss in the treatment group in the CC analysis.
X C : The mean weight loss in the control group in the CC analysis.
p T : The proportion of subjects in the treatment group who finished the trial (that is, were in the CC analysis).
p C : The proportion of subjects in the control group who finished the trial (that is, were in the CC analysis).
N T : The number of subjects randomized to the treatment group.
N C : The number of subjects randomized to the control group.
s T 2 : The estimated variance of the outcome measurement (for example, weight change) in the treatment group in a CC analysis.
The estimated variance of the outcome measurement in the control group in the CC analysis.
Derivation
It can then be shown that the mean weight loss in a BOCF analysis will be X T , BOCF ¼ X T p T in the treatment group and will be X C,BOCF ¼ X C p C in the control group, leading to a point estimate of the unstandardized treatment effect of
In deriving the variance of weight loss in the BOCF analysis, we note the within-group sums of squares for weight loss in the treatment group is SS T ¼ŝ T 2 (N T À1) and likewise the withingroup sums of squares for weight loss in the control group is SS C ¼ŝ C 2 (N C À1). From this, the within-group sums of squares for weight loss in the treatment group in the BOCF analysis is SS T;
T and the variance iŝ s T,BOCF 2 ¼ SS T,BOCF /(N T À1). Similarly, within-group sums of squares in the control group in the BOCF analysis is 
T in the treatment group and correspondingly,ŝ As can be seen in Table 1 , with an observed treatment difference between the treatment and control groups of 1.5 kg favoring treatment, both methods result in similar interpretations of intervention effects (CC: t(81) ¼ 2.024, P ¼ 0.0462; BOCF: t(116) ¼ 2.013, P ¼ 0.0464). Thus, the BOCF estimate provides more confidence in the conclusion provided using the CC analysis. Example 2 This study 11 examined the effects of 8 weeks on a very low carbohydrate, high saturated fat diet compared with a high carbohydrate, low saturated fat diet on 107 participants with abdominal obesity. Participants were randomized between treatment (N C ¼ 57) and control (N T ¼ 50) and five dropped out of the treatment group whereas three dropped out of the control group. Therefore, p C ¼ (47/50) ¼ 0.940 and p T ¼ (52/57) ¼ 0.912. A raw treatment effect was 1.3 kg, favoring treatment. In contrast to Example 1, a difference in the estimates of the treatment effects can be seen between the CC analysis and the BOCF analysis (CC: t(97) ¼ 2.339, P ¼ 0.0124 and BOCF: t(105) ¼ 1.623, P ¼ 0.1076). This suggests that in this case, the BOCF result may call into question the published conclusion drawn using the CC analysis.
Discussion
Our method has assumptions and limitations, which should be noted. First, it simply reproduces what an ordinary BOCF analysis of raw data would produce and therefore 'inherits' all the limitations of BOCFFsee ref. 9 for Discussion. Second, the t-statistic and confidence interval method derived are strictly valid in finite samples if all the GaussMarkov assumptions are met, 12 which includes normality of residuals. In BOCF, normality of residuals will almost certainly not hold and because the raw data are not available, in our approach, we cannot switch to a nonparametric analysis as one could with a raw data BOCF analysis. However, even if residuals are not normally distributed, the method is asymptotically valid and considering the typical sample sizes in obesity RCTs, nonnormality is unlikely to be problematic. The method we offer can easily be performed with an ordinary spreadsheet. Although the BOCF approach seems likely to be extremely conservative in most situations, it can provide a useful lower boundary when attempting to determine a range of treatment effect estimates as compared with CC analyses, which are often likely to be at the upper bound. This proposed method will often reduce treatment effect estimates, especially when more participants drop out in the treatment group compared with the control group as seen in Example 2. One author has argued for the validity of the BOCF approach specifically with obesity interventions, due to the evidence indicating that many persons regain most of the weight lost after many types of treatment approaches. 
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